Skip to main content

Advertisement

Table 2 Wilcoxon signed-rank test for paired samples (n = 383)

From: Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer

Marker Normal expression Median [Q1; Q3] Tumor expression Median [Q1; Q3] p-value
Nuclear Active β-catenin 2.05 [0.00; 7.12] 4.96 [0.46; 10.9] < 0.001
Total Active β-catenin 0.28 [0.13; 0.58] 0.49 [0.20; 0.89] < 0.001
HLA class I 0.29 [0.10; 0.70] 0.28 [0.16; 0.50] 0.025